Common use of Incremental Funding Clause in Contracts

Incremental Funding. The Government’s share for full performance of the Research Project Award(s) shall be determined at time of each award. In no event is the CM obligated to reimburse the Research Project Awardee for expenditures in excess of the total funds allotted by the Government under a Research Project Award, regardless of anything to the contrary in any Termination clause herein or in any Research Project Award. The CM anticipates that from time to time additional amounts will be allotted to Research Project Awards by unilateral modification, until the total Government’s share for full performance under the Research Project Award is fully funded. To minimize interruption of effort due to lack of funds, the Research Project Awardee shall notify the CM Contractual Representative in writing (electronic format acceptable) whenever the amount of funds expended under a Research Project Award, when added to anticipated costs in the next 60 calendar days, will exceed 75% of the amount allotted under the Research Project Award by the Government plus the Research Project Awardee’s corresponding share (if the Research Project Award is a cost-sharing agreement). The Research Project Awardee is not obligated to continue performance or otherwise incur costs in excess of (1) for Fixed Price Research Project Awardees the amount unfunded milestones or portions thereof, or (2) for cost reimbursement and cost plus fixed fee Research Project Awards the amount then allotted to the Research Project Award or, (3) if the Research Project Award is a cost- sharing agreement, the Research Project Awardee’s corresponding share, until the AO notifies the CM in writing and the CM notifies the Research Project Awardee recipient in writing, that the amount allotted by the Government has been increased and specifies an increased amount, which shall then constitute the total amount allotted by the Government. When and to the extent that the amount allotted by the Government to this Research Project Award is increased, any costs the Research Project Awardee incurs before the increase that are in excess of (1) the amount previously allotted by the Government or, (2) if this is a cost-sharing agreement, the amount previously allotted by the Government to the Research Project Awardee’s corresponding share, shall be allowable to the extent they would have been allowable if incurred afterward, unless the AO directs that the increase is solely to cover specific expenses.

Incremental Funding. The Government’s share for full performance of the Research Project Award(s) shall be determined at time of each award. In no event is the CM obligated to reimburse the Research Project Awardee for expenditures in excess of the total funds allotted by the Government under a Research Project Award, regardless of anything to the contrary in any Termination clause herein or in any Research Project Award. The CM anticipates that from time to time additional amounts will be allotted to Research Project Awards by unilateral modification, until the total Government’s share for full performance under the Research Project Award is fully funded. To minimize interruption of effort due to lack of funds, the Research Project Awardee shall notify the CM Contractual Representative in writing (electronic format acceptable) whenever the amount of funds expended under a Research Project Award, when added to anticipated costs in the next 60 calendar days, will exceed 75% of the amount allotted under the Research Project Award by the Government plus the Research Project Awardee’s corresponding share (if the Research Project Award is a cost-sharing agreement). The Research Project Awardee is not obligated to continue performance or otherwise incur costs in excess of (1) for Fixed Price Research Project Awardees the amount unfunded milestones or portions thereof, or (2) for cost reimbursement and cost plus fixed fee Research Project Awards the amount then allotted to the Research Project Award or, (3) if the Research Project Award is a cost- cost-sharing agreement, the Research Project Awardee’s corresponding share, until the AO notifies the CM in writing and the CM notifies the Research Project Awardee recipient in writing, that the amount allotted by the Government has been increased and specifies an increased amount, which shall then constitute the total amount allotted by the Government. When and to the extent that the amount allotted by the Government to this Research Project Award is increased, any costs the Research Project Awardee incurs before the increase that are in excess of (1) the amount previously allotted by the Government or, (2) if this is a cost-sharing agreement, the amount previously allotted by the Government to the Research Project Awardee’s corresponding share, shall be allowable to the extent they would have been allowable if incurred afterward, unless the AO directs that the increase is solely to cover specific expenses.

Incremental Funding. The Government’s share for full performance of the Research Project Award(s) Clinical Trials under this Agreement shall be determined at time of each awardonce a Clinical Trial is identified. In no event is the CM Government obligated to reimburse the Research Project Awardee recipient for expenditures in excess of the total funds allotted by the Government under for a Research Project AwardClinical Trial, regardless of anything to the contrary in any Termination clause herein or in any Research Project Awardherein. The CM Government anticipates that from time to time-to-time additional amounts will be allotted to Research Project Awards Clinical Trials under this Agreement by unilateral modificationmodification by the Government, until the total Government’s share for full performance under the Research Project Award Clinical Trial is fully funded. To minimize interruption of effort due to lack of funds, the Research Project Awardee Coordinating Center shall notify the CM Contractual Representative Government in writing (electronic format acceptable) whenever the amount of funds expended under a Research Project AwardClinical Trial, when added to anticipated costs in the next 60 calendar days, will exceed 75% of the amount allotted under the Research Project Award Clinical Trial by the Government plus the Research Project AwardeeCoordinating Center’s and Network Sites’ corresponding share (if the Research Project Award is a cost-sharing agreement)share. The Research Project Awardee is Coordinating Center and Network Sites are not obligated to continue performance or otherwise incur costs in excess of (1) for Fixed Price Research Project Awardees the amount unfunded milestones or portions thereof, or (2) for cost reimbursement and cost plus fixed fee Research Project Awards the amount then allotted to the Research Project Award Clinical Trial or, (32) if the Research Project Award Clinical Trial is a cost- cost-sharing agreement, the Research Project Awardee’s Coordinating Center or Network Sites corresponding share, until the AO notifies the CM Coordinating Center in writing and the CM notifies the Research Project Awardee recipient in writing, that the amount allotted by the Government has been increased and specifies an increased amount, which shall then constitute the total amount allotted by the Government. When and to the extent that the amount allotted by the Government to this Research Project Award Clinical Trial is increased, any costs the Research Project Awardee Coordinating Center incurs before the increase that are in excess of (1) the amount previously allotted by the Government or, (2) if this is a cost-sharing agreement, the amount previously allotted by the Government to the Research Project AwardeeCoordinating Center’s corresponding share, shall be allowable to the extent they would have been allowable if incurred afterward, unless the AO directs that the increase is solely to cover specific expenses.